Is Myeloma Research Examining Sequencing of CAR T and Bispecifics?
https://vimeo.com/930138615 Is the sequencing of CAR T-cell therapy and bispecific antibodies being examined in myeloma studies? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses what’s known about…
Targeting of Myeloma Disease Progression and Bispecific Antibody Advantages
https://vimeo.com/930138395 How can myeloma progression and bispecific antibodies be used for myeloma care? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses how disease progression and genomic features…
What Are the Latest Artificial Intelligence Advancements for Myeloma?
https://vimeo.com/930138514 What artificial intelligence advancements have emerged for myeloma? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses the IRMMa prediction model for myeloma care, factors that go…
Myeloma Patient Expert Q&A: Dr. Ola Landgren
https://vimeo.com/929981922 START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren…
Navigating Myeloma CAR T-Cell Relapse: Patient Next Steps
https://vimeo.com/922787260?fl=pl&fe=sh What are next steps for myeloma CAR T-cell patients who experience relapse? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains options for relapsed myeloma patients and shares patient advice. Download Guide…
What Factors Shape Myeloma Treatment Options After Relapse?
What myeloma treatment options are there for patients who relapse? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains patient factors that must be considered in treatment options and how treatment options may…
Navigating Priorities in the Expanding Myeloma Treatment Landscape
https://vimeo.com/922777215 What should myeloma patients know about the latest treatments and monitoring? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares updates about new research and treatments as well as new tools for…
Myeloma Patient Expert Q&A: Dr. Sikander Ailawadhi
https://vimeo.com/922790291 In this START HERE myeloma program, Dr. Sikander Ailawadhi from Mayo Clinic spotlights priorities in the rapidly expanding myeloma treatment landscape. Watch as Dr. Ailawadhi addresses pressing questions submitted…
Will Myeloma Patients Need Fewer Biopsies in the Future?
https://vimeo.com/796888337 Is it possible multiple myeloma patients will need fewer biopsies in the future? Dr. Sikander Ailawadhi from the Mayo Clinic explains bone marrow biopsies, myeloma detection, and potential tests…
How Are Myeloma Therapies and Clinical Trials Becoming More Accessible?
https://vimeo.com/796888456 For underrepresented multiple myeloma patients, what actions are being taken to improve access to care? Dr. Sikander Ailawadhi from the Mayo Clinic explains factors that can limit myeloma care…
What Treatments Are There for Myeloma Patients Who Relapse After CAR T?
https://vimeo.com/796533543 Do multiple myeloma patients who relapse after CAR T have other treatment options? Dr. Sikander Ailawadhi from the Mayo Clinic explains patients who typically receive CAR T-cell therapy and…
Myeloma Expert Gives an Overview of Novel Therapies
https://vimeo.com/796535300 What novel multiple myeloma therapies are available for patients? Dr. Sikander Ailawadhi from the Mayo Clinic shares an overview of novel therapies of CAR T-cell therapy, monoclonal antibodies, bispecifics,…